R343

DB06316InvestigationalSmall molecule

R343, was investigated in clinical trial NCT01591044 to evaluate its safety and efficacy in patients with mild to moderate asthma.

Chemical structure of R343
Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in allergic reaction and asthma.Curator reviewed
Formula / weight
C21H17F3N6O4 · 474.4 g/mol (avg)
Also known as
2- {3- [4-(2,2-Difluoro-3 -oxo-3,4-dihydro-2H-benzo [1,4] oxazin-6-ylamino)5-fluoro-pyrimidin-2-ylamino]phenoxy}N-methyl-acetamide
Code names
R-940343

Resolves to

Structure
InChIKeyMOXXQFNQDDSJHT-UHFFFAOYSA-NSMILESCNC(=O)COC1=CC=CC(NC2=NC=C(F)C(NC3=CC=C4OC(F)(F)C(=O)NC4=C3)=N2)=C1
Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with R343, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account